Blog

Blog 2018-05-14T03:59:33+00:00

Weekly Roundup for AUGUST 10, 2018: Recent Publications in Women’s Mental Health

Some interesting reviews on the list this week, including some excellent articles from leaders in the field which will be coming out in the September issue of Obstetrics & Gynecology Clinics of North America.   Ruta Nonacs, MD PhD Latent Trajectory Classes of Postpartum Depressive Symptoms: A Regional Population-Based Longitudinal Study Analyses identified two classes of women with distinct trajectories; (1) a low-risk (n?=?1 249, 91%) and (2) a high-risk group [...]

August 11th, 2018|

In Brief: Hormone Therapy for Midlife Women, No Harm but No Benefit for Cognitive Functioning

  Early observational studies suggested that hormone replacement therapy (HRT)  may improve cognitive functioning in postmenopausal women; however, larger studies, including the Women’s Health Initiative, have shown that estrogen replacement therapy started in postmenopausal women (65 years or older) did not enhance cognitive functioning, nor did HRT decrease the risk of dementia. Taking these disparate findings into consideration, researchers have proposed the hypothesis that there may be a “critical window” such [...]

August 7th, 2018|

New Research from the CWMH: Obstetrical and Neonatal Outcomes with Benzodiazepine Exposure During Pregnancy

Recent studies have demonstrated that more than 10% of women experience clinically significant symptoms of anxiety during pregnancy, particularly during the first trimester.  Anxiety during pregnancy is not necessarily a benign event.  Various studies indicate that women who experience clinically significant anxiety symptoms during pregnancy are more likely to have preterm labor and low birth weight infants, as well as other complications, including pre-eclampsia. Other studies indicate that exposure to maternal [...]

August 2nd, 2018|

Medications for Female Sexual Dysfunction: Are They Better than Placebo?

Randomized controlled trials of pharmacologic agents for the treatment of female sexual dysfunction (FSD) have typically shown significant placebo responses.  In a recent meta-analysis, researchers have assessed the magnitude of this effect. The analysis was restricted to randomized, controlled trials which used the Female Sexual Function Index to assess sexual functioning. Eight studies were included in the analysis; a total of 2,236 patients received active treatment and 1,723 patients received placebo. [...]

July 31st, 2018|

Weekly Roundup for JULY 27, 2018: Recent Publications in Women’s Mental Health

Osborne and colleagues explore the effects of maternal depression during pregnancy on the child, noting that elevated measures of inflammation and cortisol levels in the mother have an impact on stress reactivity and behavior in the child after birth.  In order to better able detect eating disorders during pregnancy, Bannatyne and colleagues identify signs and symptoms of disordered eating specific to pregnancy.   Ruta Nonacs, MD PhD Antenatal depression programs cortisol [...]

July 29th, 2018|

In Brief: Ondansetron for Nausea and Vomiting in Pregnancy, What Do We Know?

Over the last ten or so years, we have noticed a significant increase in the use of ondansetron (marketed as Zofiran) for the treatment of nausea and vomiting during pregnancy (NVP). In a recent issue of Ob-Gyn News, Dr. Christina Chambers reviews the data regarding the reproductive safety of this medication. Earlier this year, the American Congress of Obstetricians and Gynecologists (ACOG) updated its recommendation regarding nausea and vomiting in Practice [...]

July 27th, 2018|